GL1X · GenesisL1 explorer

Research workbench

Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036

Analyse Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5DFP
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase pak 1
EC
2.7.11.1
UniProt
Q13153
Ligands
59U
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase pak 1 (EC 2.7.11.1)protein29343% helix, 18% strandQ13153

Ligands and binding sites

  • 59U · 6-[2-chloro-4-(6-methylpyrazin-2-yl)phenyl]-8-ethyl-2-{[2-(1-methylpiperidin-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14280.680.804459U, DMS
2650.290.7319empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 5DFP · Crystal structure of PAK1 in complex with an inhibitor compound FRAX1036 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q13153 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase pak 1 (Q13153) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.